Clinical Trial Update: IC Plus Low-dose Radiation Plus Cadonilimab in LANPC [Phase 3]

View source ↗

Summary

A Phase 3 trial from Sun Yat-sen University is evaluating Cadonilimab in combination with low-dose radiotherapy and chemotherapy for nasopharyngeal carcinoma; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Cadonilimab

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitor | Phase 3 | Status: RECRUITING